Genetic variant in NDUFS1 gene is associated with schizophrenia and negative symptoms in Han Chinese

Journal of Human Genetics

Volumn 60, Issue 1, 2015, Pages 11-16

  Zhu, Yunlong ^a   Wang, Zhongliang ^a   Ni, Jianliang ^b   Zhang, Yi ^c   Chen, Meijuan ^c   Cai, Jun ^c   Li, Xiao ^d   Zhang, Wen ^d   Zhang, Chen ^c  

^a Department of Psychiatry   (China)

^b Tongde Hospital of Zhejiang Province   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; ISOPROTEIN; NDUFS1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SEROTONIN ANTAGONIST;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; MALE; NDUFS1 GENE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; SEX DIFFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; CLOZAPINE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NADH DEHYDROGENASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SEX FACTORS;

EID: 84922332654     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2014.94     Document Type: Article

References (39)

1. Zhang, C., Zhang, J., Fan, J., Cheng, W., Du, Y., Yu, S. et al. Identification of ANKK1 rs1800497 variant in schizophrenia: new data and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165, 564-571 (2014).
2. Tang, W. X., Cai, J., Yi, Z. H., Zhang, Y., Lu, W. H., Zhang, C. Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese. Hum. Psychopharm. Clin. 29, 100-103 (2014).
3. Zhang, C., Cai, J., Zhang, J., Li, Z., Guo, Z., Zhang, X. et al. Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 50, 110-115 (2014).
4. Goldman, A. L., Pezawas, L., Mattay, V. S., Fischl, B., Verchinski, B. A., Zoltick, B. et al. Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biol. Psychiatry 63, 475-483 (2008).
5. Robicsek, O., Karry, R., Petit, I., Salman-Kesner, N., Muller, F. J., Klein, E. et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol. Psychiatry 18, 1067-1076 (2013).
6. Ben-Shachar, D. The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia. J. Neural Transm. 116, 1383-1396 (2009).
7. Ben-Shachar, D., Karry, R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLos ONE 3, e3676 (2008).
8. Distelmaier, F., Koopman, W. J. H., van den Heuvel, L. P., Rodenburg, R. J., Mayatepek, E., Willems, P. H. G. M. et al. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 132, 833-842 (2009).
9. Ma, L., Zhang, W., Tang, J. S., Tan, L. W., Yao, Y. G., Chen, X. G. No association between genetic polymorphisms of the NDUFS7 gene and schizophrenia in Han Chinese. Psychiatr. Genet. 23, 29-32 (2013).
10. Aberg, K., Axelsson, E., Saetre, P., Jiang, L., Wetterberg, L., Pettersson, U. et al. Support for schizophrenia susceptibility locus on chromosome 2q detected in a Swedish isolate using a dense map of microsatellites and SNPs. Am. J. Med. Genet. B 147B, 1238-1244 (2008).
11. Ricci, J. E., Munoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G. A., Yadava, N. et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117, 773-786 (2004).
12. Ferreira, M., Torraco, A., Rizza, T., Fattori, F., Meschini, M. C., Castana, C. et al. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics 12, 9-17 (2011).
13. Velarde, M. C. Mitochondrial and sex steroid hormone crosstalk during aging. Longev. Healthspan 3, 2 (2014).
14. DeRosse, P., Lencz, T., Burdick, K. E., Siris, S. G., Kane, J. M., Malhotra, A. K. The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia. Schizophrenia Bull. 34, 1047-1053 (2008).
15. Zhang, Y., Chen, M., Chen, J., Wu, Z., Yu, S., Fang, Y. et al. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype. Psychopharmacology (Berl) 231, 2211-2218 (2014).
16. Zhang, Y., Chen, M., Wu, Z., Chen, J., Yu, S., Fang, Y. et al. Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results. PLos ONE 8, e72652 (2013).
17. Cai, J., Zhang, W., Yi, Z., Lu, W., Wu, Z., Chen, J. et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology (Berl.) 230, 49-55 (2013).
18. Zhang, C., Li, Z. Z., Shao, Y., Xie, B., Du, Y. S., Fang, Y. R. et al. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J. Mol. Neurosci. 43, 406-411 (2011).
19. Zhang, C., Li, Z. Z., Wu, Z. G., Chen, J., Wang, Z. W., Peng, D. H. et al. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatmentresistant major depression. Psychopharmacology 231, 685-693 (2014).
20. Park, C., Park, S. K. Molecular links between mitochondrial dysfunctions and schizophrenia. Mol. Cells 33, 105-110 (2012).
21. Rosenfeld, M., Brenner-Lavie, H., Gal-Ben Ari, S., Kavushansky, A., Ben-Shachar, D. Perturbation in mitochondrial network dynamics and in complex i dependent cellular respiration in schizophrenia. Biol. Psychiatry 69, 980-988 (2011).
22. Benit, P., Chretien, D., Kadhom, N., de Lonlay-Debeney, P., Cormier-Daire, V., Cabral, A. et al. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am. J. Hum. Genet. 68, 1344-1352 (2001).
23. Li, X., Zhang, W., Zhang, C., Gong, W., Tang, J., Yi, Z. et al. No association between genetic variants of the LRRK2 gene and schizophrenia in Han Chinese. Neurosci. Lett. 566, 210-215 (2014).
24. Zhang, W., Chen, X. G., Gong, W., Tang, J. S., Tan, L. W., Guo, H. et al. Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese. Behav. Brain Funct. 6, 75 (2010).
25. Zhang, C., Wu, Z. G., Hong, W., Wang, Z. W., Peng, D. H., Chen, J. et al. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome. J. Affect. Disorders. 155, 288-294 (2014).
26. Gasso, P., Mas, S., Molina, O., Lafuente, A., Bernardo, M., Parellada, E. Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naive first-episode schizophrenia patients. J. Psychiatr. Res. 48, 94-101 (2014).
27. Conne, B., Stutz, A., Vassalli, J.D. The 3' untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat. Med. 6, 637-641 (2000).
28. Yi, Z., Zhang, C., Wu, Z., Hong, W., Li, Z., Fang, Y. et al. Lack of effect of brain derived neurotrophic factor (BDNF) Val66Met polymorphism on early onset schizophrenia in Chinese Han population. Brain Res. 1417, 146-150 (2011).
29. Lu, W. H., Zhang, C., Yi, Z. H., Li, Z. Z., Wu, Z. G., Fang, Y. R. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naive patients with schizophrenia. J. Mol. Neurosci. 47, 505-510 (2012).
30. Wang, L. H., Chen, J. Y., Liou, Y. J., Wang, Y. C., Lai, I. C., Liao, D. L. et al. Association of missense variants of the PRKC, apoptosis, WT1, regulator (PAWR) gene with schizophrenia. Prog. Neuro-Psychopharmacol. 32, 870-875 (2008).
31. Leung, A., Chue, P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand. 101, 3-38 (2000).
32. Dato, S., Soerensen, M., Lagani, V., Montesanto, A., Passarino, G., Christensen, K. et al. Contribution of genetic polymorphisms on functional status at very old age: a gene-based analysis of 38 genes (311 SNPs) in the oxidative stress pathway. Exp. Gerontol. 52, 23-29 (2014).
33. Martin, M. A., Blazquez, A., Gutierrez-Solana, L. G., Fernandez-Moreira, D., Briones, P., Andreu, A. L. et al. Leigh syndrome associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFS1 gene. Arch. Neurol. 62, 659-661 (2005).
34. Misiak, M., Beyer, C., Arnold, S. Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons. Bba-Bioenergetics 1797, 1178-1188 (2010).
35. Cherlyn, S. Y., Woon, P. S., Liu, J. J., Ong, W. Y., Tsai, G. C., Sim, K. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance. Neurosci. Biobehav. Rev. 34, 958-977 (2010).
36. Kuperberg, G., Heckers, S. Schizophrenia and cognitive function. Curr. Opin. Neurobiol. 10, 205-210 (2000).
37. Potkin, S. G., Alva, G., Fleming, K., Anand, R., Keator, D., Carreon, D. et al. A PET study of the pathophysiology of negative symptoms in schizophrenia. Am. J. Psychiatry 159, 227-237 (2002).
38. Yacubian, J., de Castro, C. C., Ometto, M., Barbosa, E., de Camargo, C. P., Tavares, H. et al. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res. 58, 117-122 (2002).
39. Wallwork, R. S., Fortgang, R., Hashimoto, R., Weinberger, D. R., Dickinson, D. Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res. 137, 246-250 (2012).